Order Article Reprints

Viđak M, Kursar J, Bodrožić Džakić Poljak T, Letilović T, Ćatić J, Ivanović Mihajlović V, Zebić Mihić P, Manola Š, Jurin I. Heart Failure with Mid-Range or Mildly Reduced Ejection Fraction in the Era of Sodium–Glucose Co-Transporter 2 Inhibitors: Do We Now Provide Better Care for the “Middle Child of HF”? Real-World Experience from a Single Clinical Centre. Journal of Cardiovascular Development and Disease. 2024; 11(6):171. https://doi.org/10.3390/jcdd11060171

Viđak, Marin, Jelena Kursar, Tomislava Bodrožić Džakić Poljak, Tomislav Letilović, Jasmina Ćatić, Vanja Ivanović Mihajlović, Petra Zebić Mihić, Šime Manola, and Ivana Jurin. 2024. "Heart Failure with Mid-Range or Mildly Reduced Ejection Fraction in the Era of Sodium–Glucose Co-Transporter 2 Inhibitors: Do We Now Provide Better Care for the “Middle Child of HF”? Real-World Experience from a Single Clinical Centre" Journal of Cardiovascular Development and Disease 11, no. 6: 171. https://doi.org/10.3390/jcdd11060171

Viđak, M., Kursar, J., Bodrožić Džakić Poljak, T., Letilović, T., Ćatić, J., Ivanović Mihajlović, V., Zebić Mihić, P., Manola, Š., & Jurin, I. (2024). Heart Failure with Mid-Range or Mildly Reduced Ejection Fraction in the Era of Sodium–Glucose Co-Transporter 2 Inhibitors: Do We Now Provide Better Care for the “Middle Child of HF”? Real-World Experience from a Single Clinical Centre. Journal of Cardiovascular Development and Disease, 11(6), 171. https://doi.org/10.3390/jcdd11060171